NRG
39
-6
AA
34
6
XRX
48
7
ED
50
-2
EL
21
3
BIIB
51
-2
HIG
63
4
ABT
47
12
JNPR
51
2
UNP
38
12
COF
43
3
CHK
68
3
ZION
55
5
EXPD
32
-2
PNC
40
3
PM
58
-2
ORCL
58
2
V
60
2
VRTX
63
3
ETN
80
4
NRG
39
-6
AA
34
6
XRX
48
7
ED
50
-2
EL
21
3
BIIB
51
-2
HIG
63
4
ABT
47
12
JNPR
51
2
UNP
38
12
COF
43
3
CHK
68
3
ZION
55
5
EXPD
32
-2
PNC
40
3
PM
58
-2
ORCL
58
2
V
60
2
VRTX
63
3
ETN
80
4
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

Is Elon Musk right about AI?

Learn all about it here.
Buy
65

REGN
Regeneron Pharmaceuticals

Last Price:
831.44
Seasonality Move:
6.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Prepare now for a ChatGPT IPO announcement

Click here to see more

Regeneron Pharmaceuticals Price Quote

$831.44
-0.19 (0.61%)
(Updated: September 2, 2023 at 6:20 AM ET)

Regeneron Pharmaceuticals Key Stats

Buy
65
Regeneron Pharmaceuticals (REGN) is a Buy
Day range:
$829.03 - $837.92
52-week range:
$572.22 - $847.50
Dividend yield:
0%
P/E ratio:
21.76
P/S ratio:
7.46
P/B ratio:
3.76%
Volume:
252.1K
Avg. volume:
517.5K
1-year change:
38.46%
Market cap:
$90.3B
Revenue:
$12.2B
EPS:
$37.83

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.7B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.9B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.3B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 17.59%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 14.84%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 19.14%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Data Unavailable

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 13.79% 3.47%
Revenue: 10.53% 4.41%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 896.09
Upside from Last Price: 7.75%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    176.2M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    1.7M REGN shares are owned by insiders